This could be the reason why the inhibition of MyD88 failed to mitigate the severity of colitis, as evaluated by DAI, HS, and several proinflammatory cytokines, including IL-1β, IFN-γ, and TNF-α. This evidence concerns the gene IL1B and colitis.